Arthur H. Elkind

Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled Study

David W. Dodick, Alexander Mauskop, Arthur H. Elkind et al. · Headache The Journal of Head and Face Pain · 2005 · 219 citations · Full text

Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine. Results of a Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

Arthur C. Klassen, Arthur H. Elkind, Mahnaz Asgharnejad et al. · Headache The Journal of Head and Face Pain · 1997 · 112 citations

A Series of Three Sequential, Randomized, Controlled Studies of Repeated Treatments With Botulinum Toxin Type A for Migraine Prophylaxis

Arthur H. Elkind, P. O’Carroll, Andrew Blumenfeld et al. · Journal of Pain · 2006 · 87 citations

Cluster Headache, Controlled Studies, Migraine Prophylaxis +3

Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe

Roger Cady, Arthur H. Elkind, Jerome Goldstein et al. · Current Medical Research and Opinion · 2004 · 81 citations

Acetaminophen, Aspirin, and Caffeine Versus Sumatriptan Succinate in the Early Treatment of Migraine: Results From the ASSET trial

Jerome Goldstein, Stephen D. Silberstein, Joel R. Saper et al. · Headache The Journal of Head and Face Pain · 2005 · 80 citations